Given a clear trot, I shall be 83 this year. Apart from 'seeing' the difference between bright light and black, I'm now a 'total blindy’, which brings on the need for a bit of reflection.
Glaucoma management has traditionally been focused on medical therapy as initial treatment with intensification until maximum tolerated medical therapy (MTMT) is reached. Often patients end up taking multiple eyedrops several times a day, which can sometimes lead to issues with side effects and adve
As I stepped off the plane onto the sun-kissed shores of Hamilton Island for the 2024 meeting of the Australasian Society of Cataract and Refractive Surgeons (AUSCRS), I couldn’t help but feel a blend of excitement and mild dread. After all, I was about to immerse myself in a whirlwind of cutting-ed
Herpes zoster ophthalmicus recurrence: risk factors and long-term clinical outcomes
What is expected to be permanent Pharmac funding of Ilevro, a non-steroidal anti-inflammatory drop for post-cataract surgery patients, has been welcomed by New Zealand eyecare professionals.
On a chilly August evening, Greenlane Eye Clinic proudly hosted its inaugural seminar on emergency eyecare, aimed at enhancing collaboration between community optometrists and our acute eyecare team. The event began with a warm welcome from our hospital team, including optometrists Richard Johnson,
At a recent CPD event held at Southern Cross Hospital in Hamilton, optometrists from the Waikato region gathered to discuss one of the most exciting topics in eyecare today: artificial intelligence (AI). The event was a resounding success, with attendees excited about AI's potential to revolutionise
Two new international research projects at the Ocular Surface Laboratory are testing the effectiveness and safety of commercially available treatments from Alcon’s Systane range for dry eye symptoms and discomfort due to contact lens (CL)-related dryness.
Anyone who has been pregnant or lived with someone who was pregnant knows that being expectant comes with its fair share of surprises – good and bad. Changes in the release of hormones such as oestrogen, progesterone, relaxin and others incite a chain reaction with subsequent changes in vascularity,
Māori patients are disproportionately affected by diabetes in New Zealand1. The prevalence of diabetes among Māori is twice that of Pakeha1, and Māori have higher rates of diabetic complications, including hospitalisation due to end-stage renal disease, lower-limb amputations, reduced time to first
The Save Sight Dry Eye Registry (SSDER) was established by chief investigator Professor Stephanie Watson, head of the Corneal Research Group at the Save Sight Institute, University of Sydney, in 2020.
Dry eye disease (DED) is a highly prevalent condition that affects an estimated one in five adults1. However, early and accurate diagnosis of DED remains a clinical challenge as existing tests are invasive, time-consuming and inaccurate.
